| abstract |
The present invention provides a method for treating, reducing the severity of, or inhibiting the growth of, cancer (for example, B-cell cancer such as Hodgkin's lymphoma or acute lymphocytic leukemia). The methods of the present invention comprise administering a therapeutically effective amount of an antibody or antigen thereof that specifically binds to a programmed death 1 (PD-1) receptor, in combination with a therapeutically effective amount of a particular antibody that specifically binds CD20 and CD3 - binding fragment to a subject in need thereof. |